Minocycline reduces ethanol drinking

Brain, Behavior, and Immunity

Volumn 25, Issue SUPPL. 1, 2011, Pages

  Agrawal, R G ^a   Hewetson, A ^a   George, C M ^a   Syapin, P J ^a   Bergeson, S E ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

C57Bl 6J mouse; Medications development; Neuroimmune; Therapy; Voluntary consumption

Indexed keywords

MINOCYCLINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FLUID INTAKE; GLIA CELL; IMMUNOMODULATION; MACROGLIA; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL;

ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CHOICE BEHAVIOR; ETHANOL; FEMALE; FOOD PREFERENCES; MALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; SELF ADMINISTRATION; SEX FACTORS;

EID: 79955710891     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.03.002     Document Type: Article

References (20)

1. Blednov Y.A., Bergeson S.E., Walker D., Ferreira V.M., Kuziel W.A., Harris R.A. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav. Brain Res. 2005, 165:110-125.
2. Blednov, Y.A., Ponomarev, I., Geil, C., Bergeson, S., Koob, G.F., Harris, R.A., 2011. Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict. Biol. doi:. doi:10.1111/j.1369-1600.2010.00284.x.
3. Chen H., Uz T., Manev H. Minocycline affects cocaine sensitization in mice. Neurosci. Lett. 2009, 452:258-261.
4. Fan R., Xu F., Previti M.L., Davis J., Grande A.M., Robinson J.K., Van Nostrand W.E. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 2007, 27:3057-3063.
5. Hayakawa K., Mishima K., Nozako M., Hazekawa M., Mishima S., Fujioka M., Orito K., Egashira N., Iwasaki K., Fujiwara M. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 2008, 39:951-958.
6. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm. 2008, 5:15.
7. Homsi S., Federico F., Croci N., Palmier B., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res. 2009, 1291:122-132.
8. Huang T.Y., Chu H.C., Lin Y.L., Lin C.K., Hsieh T.Y., Chang W.K., Chao Y.C., Liao C.L. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol. Appl. Pharmacol. 2009, 237:69-82.
9. Jiang W., Desjardins P., Butterworth R.F. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J. Neurochem. 2009, 109:485-493.
10. Kielian T., Esen N., Liu S., Phulwani N.K., Syed M.M., Phillips N., Nishina K., Cheung A.L., Schwartzman J.D., Ruhe J.J. Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess. Am. J. Pathol. 2007, 171:1199-1214.
11. Kloppenburg M., Breedveld F.C., Terwiel J.P., Mallee C., Dijkmans B.A. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum. 1994, 37:629-636.
12. Kloppenburg M., Brinkman B.M., de Rooij-Dijk H.H., Miltenburg A.M., Daha M.R., Breedveld F.C., Dijkmans B.A., Verweij C. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob. Agents Chemother. 1996, 40:934-940.
13. Mishra M.K., Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J. Neurochem. 2008, 105:1582-1595.
14. Nikodemova M., Lee J., Fabry Z., Duncan I.D. Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord. J. Neuroimmunol. 2010, 219:33-37.
15. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol. 2002, 51:215-223.
16. Roulston C.L., Lawrence A.J., Widdop R.E., Jarrott B. Minocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomy. Neuroscience 2005, 135:1241-1253.
17. Sewell K.L., Breedveld F., Furrie E., O'Brien J., Brinckerhoff C., Dynesius-Trentham R., Nosaka Y., Trentham D.E. The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux. Cell. Immunol. 1996, 167:195-204.
18. Tanibuchi Y., Shimagami M., Fukami G., Sekine Y., Iyo M., Hashimoto K. A case of methamphetamine use disorder treated with the antibiotic drug minocycline. Gen. Hosp. Psychiatry 2010, 32:559. e551-e553.
19. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I.G., Cattaneo E., Ferrante R.J., Kristal B.S., Friedlander R.M. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc. Natl. Acad. Sci. USA 2003, 100:10483-10487.
20. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22:1763-1771.